QuVa Pharma Secures National Drug Diversion Software Agreement with Premier

May 05, 2026
QuVa Pharma has been awarded a national group purchasing agreement with Premier, Inc. for its Drug Diversion Software Solutions, effective May 1, 2026. The deal enables Premier members to access pre-negotiated pricing and terms for QuVa's BrightStream platform, which supports controlled substance oversight and compliance.

QuVa Pharma has been awarded a national group purchasing agreement with Premier, Inc. for its Drug Diversion Software Solutions, announced in a press release. The agreement took effect on May 1, 2026, and allows Premier members to access special pricing and terms negotiated by Premier.

The partnership expands QuVa's relationship with Premier through its BrightStream platform, which uses analytics to help health systems monitor and manage diversion risk. The software provides visibility into controlled substance activity, supports investigations, and generates documentation for regulatory compliance.

According to QuVa, BrightStream also offers reporting, benchmarking, and workflow management tools that unify pharmacy, nursing, and compliance operations. The platform aims to replace manual processes with standardized oversight across hospital systems.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Enterprise AI Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Enterprise

05/05
GLG Relaunches myGLG Platform with AI Research Tools
05/05
Stellanor Acquires Eight Data Centers from Redcentric
05/05
Dun & Bradstreet Integrates Risk Data into Anthropic’s Claude for Automated Compliance Workflows
05/05
Spacelift Adds Senior Leaders in Sales and Product as Platform Expansion Accelerates
05/05
IBM and Aramco Plan Collaboration on Industrial AI in Saudi Arabia

More from: Life Sciences

05/05
Village Raises $9.5 Million to Expand AI Pediatric Care Platform
05/05
Verana Health Expands Clinical Trial Tools with Real World Data Integration
05/05
Andrew Viterbi Donates $5 Million to Sanford Burnham Prebys for AI Research
05/05
Pair Team Joins CMS ACCESS Model to Expand AI Care for Medicare Patients
05/05
West Coast Informatics Launches AutomapAI for Clinical Data Normalization

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

2025 State of Data Security Report: Quantifying AI’s Impact on Data Risk

Varonis Systems, Inc.

The 2025 State of Data Security Report by Varonis analyzes the impact of AI on data security across 1,000 IT environments. It highlights critical vulnerabilities such as exposed sensitive cloud data, ghost users, and unsanctioned AI applications. The report emphasizes the need for robust data governance and security measures to mitigate AI-related risks.

Read more

You May Also Like